Relmada Therapeutics
RLMD
Insider trades and stock quote 2024-2026
All insider trades at Relmada Therapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
9/10/2026
|
Buy |
Traversa, Sergio |
Chief Executive Officer |
$4.1 |
$410,000 |
|
9/10/2026
|
Buy |
Shenouda, Maged |
Chief Financial Officer |
$4.2 |
$339,150 |
|
9/9/2026
|
Buy |
Traversa, Sergio |
Chief Executive Officer |
$4.2 |
$418,000 |
|
9/9/2026
|
Buy |
Shenouda, Maged |
Chief Financial Officer |
$4.2 |
$504,840 |
|
12/15/2025
|
Buy |
Shenouda, Maged |
Chief Financial Officer |
$4.1 |
$48,060 |
|
12/15/2025
|
Buy |
Traversa, Sergio |
Chief Executive Officer |
$4.1 |
$113,300 |
|
11/5/2025
|
Buy |
Kelly, Paul Edward |
Chief Operating Officer |
$2.2 |
$198,000 |
|
11/5/2025
|
Buy |
Shenouda, Maged |
Chief Financial Officer |
$2.2 |
$1,100,000 |
|
11/5/2025
|
Buy |
Traversa, Sergio |
Chief Executive Officer |
$2.2 |
$599,500 |
|
11/5/2025
|
Buy |
Ence, Chuck |
CAO and COO |
$2.2 |
$299,200 |
|
8/28/2025
|
Buy |
Traversa, Sergio |
Chief Executive Officer |
$0.7 |
$41,422 |
|
8/27/2025
|
Buy |
Traversa, Sergio |
Chief Executive Officer |
$0.7 |
$86,735 |
|
8/26/2025
|
Buy |
Traversa, Sergio |
Chief Executive Officer |
$0.6 |
$49,938 |
|
5/20/2025
|
Buy |
Traversa, Sergio |
Chief Executive Officer |
$0.6 |
$82,246 |
|
5/20/2025
|
Buy |
Shenouda, Maged |
Chief Financial Officer |
$0.5 |
$31,422 |
|
5/19/2025
|
Buy |
Traversa, Sergio |
Chief Executive Officer |
$0.5 |
$14,994 |
|
5/19/2025
|
Buy |
Shenouda, Maged |
Chief Financial Officer |
$0.5 |
$43,686 |
|
5/16/2025
|
Buy |
Traversa, Sergio |
Chief Executive Officer |
$0.4 |
$77,472 |
|
5/16/2025
|
Buy |
Ence, Chuck |
CA and CO |
$0.5 |
$103,330 |
|
5/16/2025
|
Buy |
Shenouda, Maged |
Chief Financial Officer |
$0.4 |
$22,100 |
|
5/16/2025
|
Buy |
Kelly, Paul Edward |
Chief Operating Officer |
$0.4 |
$86,060 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address